+

WO2004007540A8 - Extraits membranaires de klebsiella presentant des proprietes avantageuses, et procede de production de ces extraits - Google Patents

Extraits membranaires de klebsiella presentant des proprietes avantageuses, et procede de production de ces extraits

Info

Publication number
WO2004007540A8
WO2004007540A8 PCT/FR2003/002185 FR0302185W WO2004007540A8 WO 2004007540 A8 WO2004007540 A8 WO 2004007540A8 FR 0302185 W FR0302185 W FR 0302185W WO 2004007540 A8 WO2004007540 A8 WO 2004007540A8
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
producing
advantageous properties
klebsiella
exhibiting advantageous
Prior art date
Application number
PCT/FR2003/002185
Other languages
English (en)
Other versions
WO2004007540A1 (fr
Inventor
Dominique Rigal
Daniel Masseau
Original Assignee
Lco Sante
Dominique Rigal
Daniel Masseau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lco Sante, Dominique Rigal, Daniel Masseau filed Critical Lco Sante
Priority to AU2003271802A priority Critical patent/AU2003271802A1/en
Publication of WO2004007540A1 publication Critical patent/WO2004007540A1/fr
Publication of WO2004007540A8 publication Critical patent/WO2004007540A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention porte sur des extraits bactériens, en particulier des extraits de Klebsiella, plus particulièrement de Klebsiella pneumoniae, présentant des propriétés avantageuses, notamment, dans plusieurs applications, une activité accrue par rapport aux extraits de Klebsiella déjà connus. Le procédé de production de ces extraits fait aussi partie de la présente invention.
PCT/FR2003/002185 2002-07-10 2003-07-10 Extraits membranaires de klebsiella presentant des proprietes avantageuses, et procede de production de ces extraits WO2004007540A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003271802A AU2003271802A1 (en) 2002-07-10 2003-07-10 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/08698 2002-07-10
FR0208698A FR2842208B1 (fr) 2002-07-10 2002-07-10 Extraits membranaires de klebsiella presentant des proprietes avantageuses, et procede de production de ces extraits

Publications (2)

Publication Number Publication Date
WO2004007540A1 WO2004007540A1 (fr) 2004-01-22
WO2004007540A8 true WO2004007540A8 (fr) 2004-07-01

Family

ID=29763719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002185 WO2004007540A1 (fr) 2002-07-10 2003-07-10 Extraits membranaires de klebsiella presentant des proprietes avantageuses, et procede de production de ces extraits

Country Status (3)

Country Link
AU (1) AU2003271802A1 (fr)
FR (1) FR2842208B1 (fr)
WO (1) WO2004007540A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US20020034522A1 (en) * 1998-03-13 2002-03-21 Flynn, Thiel, Boutell, And Tanis, P.C. Use of a strain of pasteurella haemolytica of a particular serotype for preparing a vaccine against bovine pasteurellosis due to pasteurella haemolytica

Also Published As

Publication number Publication date
FR2842208B1 (fr) 2004-10-22
WO2004007540A1 (fr) 2004-01-22
FR2842208A1 (fr) 2004-01-16
AU2003271802A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
WO2005094235A3 (fr) Flocons de soja grillés et leur procédé de fabrication
WO2006102652A3 (fr) Expression de glycosyltransferases eucaryotiques solubles, actives dans des organismes procaryotiques
WO2007053731A3 (fr) Expression de protéines solubles du facteur viii chez les bactéries
WO2005065072A3 (fr) Systemes et methodes d'electropulverisation
WO2006089665A3 (fr) Combinaisons de principes actifs ayant des proprietes insecticides et acaricides
WO2007047468A3 (fr) Immunomodulation realisee avec des cellules souches placentaires
WO2004052522A3 (fr) Produits solubles dans l'eau et procedes de production et d'utilisation de ces derniers
CA2419673A1 (fr) Reseaux polymeriques
AU2003270163A1 (en) Methods for producing an anti-microbial plastic product
WO2005060707A3 (fr) Procedes d'utilisation de lactobacilli probiotiques chez des animaux de compagnie
WO2007014197A3 (fr) Vecteurs d'expression de levures pour la production du facteur itf
WO2003013435A3 (fr) N-acetyle-d-glucosamine et procede de production de la n-acetyle-d-glucosamine
WO2007112279A3 (fr) Résonateurs
WO2002101049A3 (fr) Production et utilisation de mutants d'interleukine-18
WO2005037470A3 (fr) Nanoparticules encapsulees, produits contenant ces nanoparticules et procedes pour les utiliser
AU2003245928A1 (en) Antibacterial amide macrocycles
WO2004055117A3 (fr) Colorants substitues par carboxamide pour applications analytiques
WO2004007664A3 (fr) Vecteurs d'acides nucleiques
CA2527630A1 (fr) Compositions aqueuses a base de polychloroprene
WO2005040107A3 (fr) Procedes pour fabriquer la simvastatine et leurs intermediaires
WO2004031202A3 (fr) Palatinose condense sous forme hydrogenee
WO2006050341A3 (fr) Polysaccharides streptococciques modifies et leurs utilisations
AU2002343876A1 (en) Woody molding, its production system and production method
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
CA2476244A1 (fr) Autolysat bacterien

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE IN FRENCH REPLACED BY CORRECT TITLE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载